RECENT ARTICLES
U.S. prepares push to reduce 'unnecessary' COVID-19 testing: official
By , (Reuters) - The United States is preparing to issue guidance on reducing “unnecessary” testing for COVID-19 as it works to cut turnaround times for tests, a senior U.S. health official said on Thursday.Details of the guidance are still being hammered out but it would be aimed partly at discouraging COVID-19 patients who have completed home quarantine from getting retested before returning to work or school, said Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services.Speaking on a call with reporters, he said such unnecessary tests were...…By , (Reuters) - The United States is preparing to issue guidance on reducing “unnecessary” testing for COVID-19 as it works to cut turnaround times for tests, a senior U.S. health official said on Thursday.Details of the guidance are still being hammered out but it would be aimed partly at discouraging COVID-19 patients who have completed home quarantine from getting retested before returning to work or school, said Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services.Speaking on a call with reporters, he said such unnecessary tests were...WW…
Exclusive: J&J in talks with Japan, Gates Foundation to lock in deals on COVID-19 vaccine
By , More than a hundred vaccines are under development to try and stop the COVID-19 pandemic, and drugmakers including J&J are working to ramp up supply for their vaccines in the face of unprecedented demand.J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA), Wolk said.The Bill and Melinda Gates Foundation would focus on allocating any vaccine it acquired to developing countries, Wolk added. Reuters previously reported that J&J is also...…By , More than a hundred vaccines are under development to try and stop the COVID-19 pandemic, and drugmakers including J&J are working to ramp up supply for their vaccines in the face of unprecedented demand.J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA), Wolk said.The Bill and Melinda Gates Foundation would focus on allocating any vaccine it acquired to developing countries, Wolk added. Reuters previously reported that J&J is also...WW…
Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses
By , (Reuters) - Wall Street is moving some bets on COVID-19 vaccines to large pharmaceutical companies with robust manufacturing capabilities, signaling that a love affair with small biotech firms might be ending after the sector’s best quarter in almost 20 years.Some of the selling was likely driven by end-of-quarter profit-taking, locking in dizzying gains in an otherwise turbulent market. Moderna and Inovio shares have risen nearly 200 percent and 540 percent in the year-to-date, respectively, greatly eclipsing gains for large pharmaceutical companies.Analysts say investors are changing...…By , (Reuters) - Wall Street is moving some bets on COVID-19 vaccines to large pharmaceutical companies with robust manufacturing capabilities, signaling that a love affair with small biotech firms might be ending after the sector’s best quarter in almost 20 years.Some of the selling was likely driven by end-of-quarter profit-taking, locking in dizzying gains in an otherwise turbulent market. Moderna and Inovio shares have risen nearly 200 percent and 540 percent in the year-to-date, respectively, greatly eclipsing gains for large pharmaceutical companies.Analysts say investors are changing...WW…
Black Americans hospitalized for COVID-19 at four times the rate of whites, Medicare data shows
By , (Reuters) - Black Americans enrolled in Medicare were around four times as likely as their white counterparts to be hospitalized for COVID-19, U.S. government data released on Monday showed, highlighting significant racial disparities in health outcomes during the pandemic.“The disparities in the data reflect longstanding challenges facing minority communities and low income older adults,” said Seema Verma, administrator of the Centers for Medicare & Medicaid Services (CMS), which released the data.The data showed that more than 325,000 Medicare beneficiaries were diagnosed with...…By , (Reuters) - Black Americans enrolled in Medicare were around four times as likely as their white counterparts to be hospitalized for COVID-19, U.S. government data released on Monday showed, highlighting significant racial disparities in health outcomes during the pandemic.“The disparities in the data reflect longstanding challenges facing minority communities and low income older adults,” said Seema Verma, administrator of the Centers for Medicare & Medicaid Services (CMS), which released the data.The data showed that more than 325,000 Medicare beneficiaries were diagnosed with...WW…
Pfizer, BioNTech set to begin U.S. coronavirus vaccine trial
By , The U.S. drugmaker and German partner said if the vaccine proves to be safe and effective in trials, it could potentially be ready for wide U.S. distribution by the end of the year, shaving several years off the typical vaccine development timeline.The vaccine, which uses messenger RNA (mRNA) technology, has the potential to be among the first vaccines against the virus that has infected more than 1 million people in the United States and killed some 68,000.There are currently no approved treatments or vaccines for the new coronavirus, though some drugs are being used on patients under...…By , The U.S. drugmaker and German partner said if the vaccine proves to be safe and effective in trials, it could potentially be ready for wide U.S. distribution by the end of the year, shaving several years off the typical vaccine development timeline.The vaccine, which uses messenger RNA (mRNA) technology, has the potential to be among the first vaccines against the virus that has infected more than 1 million people in the United States and killed some 68,000.There are currently no approved treatments or vaccines for the new coronavirus, though some drugs are being used on patients under...WW…
Johnson & Johnson to stop selling talc baby powder in U.S. and Canada
By , (Reuters) - Johnson & Johnson will stop selling its talc Baby Powder in the United States and Canada, it announced on Tuesday, saying demand had fallen in the wake of what it called “misinformation” about the product’s safety amid a barrage of legal challenges.J&J faces more than 19,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with asbestos, a known carcinogen. Many are pending before a U.S. district judge in New Jersey.“I wish my mother could be here to see this day,” said Crystal Deckard, whose mother Darlene...…By , (Reuters) - Johnson & Johnson will stop selling its talc Baby Powder in the United States and Canada, it announced on Tuesday, saying demand had fallen in the wake of what it called “misinformation” about the product’s safety amid a barrage of legal challenges.J&J faces more than 19,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with asbestos, a known carcinogen. Many are pending before a U.S. district judge in New Jersey.“I wish my mother could be here to see this day,” said Crystal Deckard, whose mother Darlene...WW…
- Total 6 items
- 1